MYC and cancer: In consistent, the critical roles of both c-Myc and PI3K pathways in determining the sensitivity extent of cancer cells to the anti-cancer agents have been reported in our recent investigations, indicating that the suppression of these onco-proteines may be a beneficial approach in combined-modal strategies (35-39).